Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Federal Circuit U.S. Court of Appeals | |
Case #: | 0:24-cvpri-02002 |
Type | civil private |
Nature of Suit | 830 Property Rights - Patent |
Case Filed: | Jun 25, 2024 |
Last checked: Wednesday Jun 26, 2024 5:18 AM EDT |
Defendant
AMGEN USA, INC.
|
|
Defendant
CELLTRION, INC.
|
|
Defendant
SAMSUNG BIOEPIS CO., LTD.
|
|
Defendant
FORMYCON AG
|
|
Defendant
AMGEN INC.
|
|
Defendant - Appellant
MYLAN PHARMACEUTICALS INC.
|
Represented By
|
Defendant - Appellant
BIOCON BIOLOGICS INC.
|
Represented By
|
Plaintiff - Appellee
REGENERON PHARMACEUTICALS, INC.
|
Represented By
|
Docket last updated: 06/26/2024 4:30 AM EDT |